This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Expleo Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve the Audited Financial Results ....
EXPLEOSOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.1 pts less than its IT Enabled Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Expleo Solutions has informed BSE that its Board of Directors will meet on Thursday, May 22, 2025 to consider and approve the Audited Standalone Financial Results for the financial year ended March 31, 2025. The board will also consider and approve the Audited Consolidated Financial Results for the same period. The filing is a routine compliance disclosure under SEBI Listing Regulations and does not contain any actual financial figures. Investors will get the FY25 numbers only after the board meeting concludes.
This is a procedural notice with no direct impact on the stock. Shareholders should watch for the actual audited FY25 results on May 22, 2025 to evaluate the company's full-year performance.
| Q4 FY25 | Q4 FY24 | Change | |
|---|---|---|---|
| Revenue | ₹255.8 Cr | ₹255.4 Cr | +0.2% |
| Operating profit | ₹31.01 Cr | ₹24.38 Cr | +27.2% |
| Profit after tax | ₹24.08 Cr | ₹15.70 Cr | +53.4% |
| EBITDA margin | 15.6% | 13.4% | +2.2 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.